rs146411944

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_003737.4(DCHS1):​c.5938A>T​(p.Thr1980Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00166 in 1,612,600 control chromosomes in the GnomAD database, including 48 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. T1980T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0023 ( 7 hom., cov: 33)
Exomes 𝑓: 0.0016 ( 41 hom. )

Consequence

DCHS1
NM_003737.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.11

Publications

2 publications found
Variant links:
Genes affected
DCHS1 (HGNC:13681): (dachsous cadherin-related 1) This gene is a member of the cadherin superfamily whose members encode calcium-dependent cell-cell adhesion molecules. The encoded protein has a signal peptide, 27 cadherin repeat domains and a unique cytoplasmic region. This particular cadherin family member is expressed in fibroblasts but not in melanocytes or keratinocytes. The cell-cell adhesion of fibroblasts is thought to be necessary for wound healing. [provided by RefSeq, Jul 2008]
DCHS1 Gene-Disease associations (from GenCC):
  • mitral valve prolapse, myxomatous 2
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • van Maldergem syndrome 1
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia
  • familial mitral valve prolapse
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • van Maldergem syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0021868944).
BP6
Variant 11-6627101-T-A is Benign according to our data. Variant chr11-6627101-T-A is described in ClinVar as Benign. ClinVar VariationId is 376899.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00227 (344/151782) while in subpopulation AMR AF = 0.0157 (239/15246). AF 95% confidence interval is 0.014. There are 7 homozygotes in GnomAd4. There are 158 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 7 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DCHS1NM_003737.4 linkc.5938A>T p.Thr1980Ser missense_variant Exon 14 of 21 ENST00000299441.5 NP_003728.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DCHS1ENST00000299441.5 linkc.5938A>T p.Thr1980Ser missense_variant Exon 14 of 21 1 NM_003737.4 ENSP00000299441.3

Frequencies

GnomAD3 genomes
AF:
0.00225
AC:
342
AN:
151664
Hom.:
6
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00119
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0155
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00271
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000284
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000471
Gnomad OTH
AF:
0.00385
GnomAD2 exomes
AF:
0.00595
AC:
1488
AN:
250284
AF XY:
0.00465
show subpopulations
Gnomad AFR exome
AF:
0.000684
Gnomad AMR exome
AF:
0.0387
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00147
Gnomad FIN exome
AF:
0.000370
Gnomad NFE exome
AF:
0.000709
Gnomad OTH exome
AF:
0.00393
GnomAD4 exome
AF:
0.00160
AC:
2331
AN:
1460818
Hom.:
41
Cov.:
71
AF XY:
0.00140
AC XY:
1019
AN XY:
726632
show subpopulations
African (AFR)
AF:
0.000478
AC:
16
AN:
33476
American (AMR)
AF:
0.0366
AC:
1636
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00461
AC:
183
AN:
39684
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86252
European-Finnish (FIN)
AF:
0.000303
AC:
16
AN:
52852
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5766
European-Non Finnish (NFE)
AF:
0.000354
AC:
393
AN:
1111590
Other (OTH)
AF:
0.00139
AC:
84
AN:
60344
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
169
338
506
675
844
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00227
AC:
344
AN:
151782
Hom.:
7
Cov.:
33
AF XY:
0.00213
AC XY:
158
AN XY:
74200
show subpopulations
African (AFR)
AF:
0.00118
AC:
49
AN:
41386
American (AMR)
AF:
0.0157
AC:
239
AN:
15246
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00252
AC:
13
AN:
5156
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4790
European-Finnish (FIN)
AF:
0.000284
AC:
3
AN:
10546
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000471
AC:
32
AN:
67880
Other (OTH)
AF:
0.00381
AC:
8
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
17
34
51
68
85
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000672
Hom.:
1
Bravo
AF:
0.00385
ESP6500AA
AF:
0.00114
AC:
5
ESP6500EA
AF:
0.000466
AC:
4
ExAC
AF:
0.00492
AC:
597
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000178

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Feb 07, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 09, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
13
DANN
Benign
0.70
DEOGEN2
Benign
0.051
T
Eigen
Benign
-0.70
Eigen_PC
Benign
-0.55
FATHMM_MKL
Benign
0.57
D
LIST_S2
Benign
0.54
T
MetaRNN
Benign
0.0022
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-0.69
N
PhyloP100
1.1
PrimateAI
Benign
0.37
T
PROVEAN
Benign
-0.080
N
REVEL
Benign
0.098
Sift
Benign
0.74
T
Sift4G
Benign
0.17
T
Polyphen
0.0020
B
Vest4
0.11
MutPred
0.27
Gain of phosphorylation at T1980 (P = 0.0723);
MVP
0.46
MPC
0.17
ClinPred
0.0034
T
GERP RS
4.0
Varity_R
0.019
gMVP
0.18
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146411944; hg19: chr11-6648332; API